Detalles de la búsqueda
1.
Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacy.
Dermatol Ther
; 35(3): e15275, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34923732
2.
Similar pharmacokinetics of three dosing regimens comprising two oral delayed-release mesalamine formulations in healthy adult volunteers: Randomised, open-label, parallel-group study.
Br J Clin Pharmacol
; 87(3): 1141-1149, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32671846
3.
A Single Supratherapeutic Dose of Atogepant Does Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized, Single-Dose, Phase 1 Crossover Trial.
Clin Pharmacol Drug Dev
; 10(9): 1099-1107, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33942560
4.
Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers.
Clin Pharmacol
; 11: 93-101, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31372067
5.
Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study.
J Clin Aesthet Dermatol
; 12(11): E53-E62, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32038757
Resultados
1 -
5
de 5
1
Próxima >
>>